Aisling Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $10M | Hold |
|
|||||
|
2024
Q3 | $2.98M | Hold |
|
|||||
|
2024
Q2 | $3.05M | Hold |
|
|||||
|
2024
Q1 | $3.33M | Hold |
|
|||||
|
2023
Q4 | $3.51M | Hold |
|
|||||
|
2023
Q3 | $2.48M | Hold |
|
|||||
|
2023
Q2 | $1.84M | Hold |
|
|||||
|
2023
Q1 | $3.21M | Hold |
|
|||||
|
2022
Q4 | $5.53M | Hold |
|
|||||
|
2022
Q3 | $3.68M | Hold |
|
|||||
|
2022
Q2 | $2.69M | Hold |
|
|||||
|
2022
Q1 | $4.67M | Hold |
|
|||||
|
2021
Q4 | $7.11M | Hold |
|
|||||
|
2021
Q3 | $7.61M | Hold |
|
|||||
|
2021
Q2 | $10.5M | Hold |
|
|||||
|
2021
Q1 | $9.96M | Hold |
|
|||||
|
2020
Q4 | $11.4M | Hold |
|
|||||
|
2020
Q3 | $9.25M | Buy |
|